FREQUENCY AND ROLE OF APO-E PHENOTYPE IN FAMILIAL HYPERCHOLESTEROLEMIA AND NONFAMILIAL HYPERLIPIDEMIA IN THE JAPANESE

被引:11
|
作者
KITAHARA, M
SHINOMIYA, M
SHIRAI, K
SAITO, Y
YOSHIDA, S
机构
[1] Second Department of Internal Medicine, School of Medicine, Chiba University, Chiba
关键词
Apo E phenotype; Apolipoprotein; Familial hypercholesterolemia; IDL; Lipoprotein metabolism; VLDL;
D O I
10.1016/0021-9150(90)90041-G
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The frequencies of the major apolipoprotein E(apo E) phenotypes in 65 normal, 426 hyperlipidemics, and 92 familial hypercholesterolemic Japanese subjects (FH) were studied, and features of hyperlipidemia compared between non-FH hyperlipidemia and FH. The frequencies of apo E phenotypes 3/3, 4/3, 3/2, 4/4 were almost the same in normal, non-FH hyperlipidemic, and FH subjects. The incidence of apo E7 was about 0.50 of total subjects. In type IV and V hyperlipidemias, incidence of E4/3 was higher than in any other hyperlipidemia. Incidence of E3/2 was also high in types III and V. In type II non-FH hyperlipidemia, incidence of E3/2 in type IIb was higher than in type Ila. VLDL-triglyceride, VLDL-cholesterol, apo C-II, apo C-III, and apo E levels were higher in E3/2 than in E3/3. But, in type IIa FH and type IIb FH, the incidence of E3/2 was the same, and lipid and apolipoprotein levels between 3/2 and 3/3 in FH were the same. These results indicate that allele ε{lunate}2 may be involved in the retention of VLDL or IDL, but not in FH. © 1990.
引用
收藏
页码:197 / 204
页数:8
相关论文
共 50 条
  • [1] POLYMORPHISM OF APO-E, HYPERLIPIDEMIA AND ATHEROSCLEROSIS
    DAVIGNON, J
    LUSSIERCACAN, S
    BOUTHILLIER, D
    SING, CF
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1986, 79 (01): : 120 - 120
  • [2] APO-E PHENOTYPE IN ATHEROMATOUS PLAQUES
    VENARUCCI, D
    STROKE, 1994, 25 (11) : 2296 - 2297
  • [3] VLDL APO-B-100 AND APO-E KINETICS IN FAMILIAL HYPERCHOLESTEROLEMIA USING STABLE ISOTOPES
    SCHAEFER, JR
    GREGG, RE
    FAIRWELL, T
    ZECH, LA
    RADER, DJ
    KINDT, MR
    BREWER, HB
    ARTERIOSCLEROSIS, 1989, 9 (05): : A713 - A713
  • [4] INFLUENCE OF APO-E POLYMORPHISM ON THE RESPONSE TO SIMVASTATIN TREATMENT IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    DEKNIJFF, P
    STALENHOEF, AFH
    MOL, MJTM
    LEUVEN, JAG
    SMIT, J
    ERKELENS, DW
    SCHOUTEN, J
    FRANTS, RR
    HAVEKES, LM
    ATHEROSCLEROSIS, 1990, 83 (01) : 89 - 97
  • [5] APO-B AND APO-E METABOLISM BEFORE AND AFTER PORTACAVAL-SHUNT IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    GABELLI, C
    GREGG, RE
    ZECH, LA
    HOEG, JM
    BREWER, HB
    ARTERIOSCLEROSIS, 1984, 4 (05): : A520 - A520
  • [6] GENETIC-POLYMORPHISM OF APOLIPOPROTEIN-E AND HYPERLIPIDEMIA IN JAPANESE .4. APO E4 PHENOTYPE AND HYPERCHOLESTEROLEMIA
    YAMANOUCHI, Y
    TSUCHIYA, S
    YANAGI, H
    MIYAZAKI, R
    HAMAGUCHI, H
    JAPANESE JOURNAL OF HUMAN GENETICS, 1988, 33 (02): : 228 - 228
  • [7] THE SEVERITY OF CORONARY ATHEROSCLEROSIS AND APO-E PHENOTYPE
    TSENG, JK
    SAKU, K
    KAWANO, T
    SASAKI, J
    ARAKAWA, K
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1988, 52 (09): : 1025 - 1026
  • [8] APO-E PHENOTYPE IN ATHEROMATOUS PLAQUES - REPLY
    BAILLEUL, S
    COUDERC, R
    MAHIEUX, F
    STROKE, 1994, 25 (11) : 2297 - 2297
  • [9] APOLIPOPROTEIN-EBETHESDA, A VARIANT OF APO-E ASSOCIATED WITH HYPERLIPIDEMIA
    GREGG, RE
    GHISELLI, G
    BREWER, HB
    ARTERIOSCLEROSIS, 1982, 2 (05): : A420 - A420
  • [10] APO-E MESSENGER-RNA AND PROTEIN-SYNTHESIS ABNORMALITIES IN A PATIENT WITH FAMILIAL PLASMA APO-E DEFICIENCY
    ZANNIS, VI
    ORDOVAS, JM
    CLADARAS, C
    SCHAEFER, EJ
    ARTERIOSCLEROSIS, 1985, 5 (05): : A503 - A503